AER Bills Likely To See Action In November Lame Duck Session
This article was originally published in The Tan Sheet
Executive Summary
Both the House and the Senate versions of the Adverse Event Reporting bill may be acted on in the week after November elections, according to the United Natural Products Alliance
You may also be interested in...
Democrats Expected To Put Supplement, Drug Regulation Under Microscope
Increased scrutiny of issues including the safety of dietary supplements and phenylephrine efficacy is likely as senior Democrats move into leadership roles on Congressional committees following the 2006 midterm elections
Senate Vote On Adverse Event Reporting Bill Expected By October
The Senate likely will vote on the "Dietary Supplement & Nonprescription Drug Consumer Protection Act" (S 3546) before they adjourn in early October, according to several supplement industry trade groups
Bipartisan AER Bill Requires Reporting For All OTC Drugs, Supplements
Manufacturers of nonprescription drugs and dietary supplements will have to provide company contact information on product labels in order for consumers to report serious adverse events associated with the products under long-awaited legislation introduced June 21